Synchronous occurrence of breast cancer and pulmonary sclerosing hemangioma: Management and review of the literature

2013 ◽  
Vol 34 (2) ◽  
pp. 61-65
Author(s):  
Nikolaos S. Salemis ◽  
Charalampos Seretis ◽  
Georgios Nakos ◽  
Ioannis Kantounakis ◽  
Charalampos Stoumpos ◽  
...  
2016 ◽  
Vol 6 (2) ◽  
pp. 221-224 ◽  
Author(s):  
Le Zhou ◽  
Chuntang Sun ◽  
Yan Huang ◽  
Qiao Li ◽  
Huairong Tang ◽  
...  

2019 ◽  
Vol 19 (2) ◽  
pp. e271-e275 ◽  
Author(s):  
Sara Tanini ◽  
Alessandra D. Fisher ◽  
Icro Meattini ◽  
Simonetta Bianchi ◽  
Jiska Ristori ◽  
...  

2021 ◽  
pp. 1071-1079
Author(s):  
Jennifer Y. Ge ◽  
Beth Overmoyer

Inflammatory breast cancer (IBC) is a rare type of breast cancer that is associated with poor outcomes compared with non-IBC. Overexpression of HER2 is enriched in IBC, and those with HER2-positive disease have a relatively favorable prognosis, with improved survival over the last two decades driven by the advent of novel targeted therapies. Here, we present two patients who have survived for over 10 years after being diagnosed with de novo metastatic HER2-positive IBC. We review the data for the treatments available for metastatic HER2-positive IBC and the evolving treatment recommendations for this disease.


2019 ◽  
Vol 12 (4) ◽  
pp. 189-193 ◽  
Author(s):  
Jonathan T. Kapke ◽  
Robert J. Schneidewend ◽  
Zeeshan A. Jawa ◽  
Chiang-Ching Huang ◽  
Jennifer M. Connelly ◽  
...  

2016 ◽  
Vol 22 (4) ◽  
pp. 451-455
Author(s):  
Nicole M. Zaremba ◽  
Deimante Tamkus ◽  
Luciano DiCarlo ◽  
James Herman ◽  
Mersadies Martin ◽  
...  

2008 ◽  
Vol 27 (1) ◽  
pp. 113-117 ◽  
Author(s):  
Natalina Manci ◽  
Claudia Marchetti ◽  
Francesca Esposito ◽  
Marialida Graziano ◽  
Federica Tomao ◽  
...  

2016 ◽  
Vol 30 (1) ◽  
pp. 57-63
Author(s):  
Toshihiro Ojima ◽  
Saya Miyahara ◽  
Shigeki Sugiyama ◽  
Hiroshi Kajiwara ◽  
Yoshinori Doki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document